Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women

Clinical trial NCT05439902 · UNKNOWN

Trial details

NCT number: NCT05439902
Sponsor: Centre Hospitalier Universitaire de Nīmes
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Multiple Sclerosis Dysuria Lower Urinary Tract Symptoms Voiding Dysfunction Urinary Retention

Start date: 2022-10-05
Primary completion: 2026-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.